< Back to previous page
Researcher
Heidi Segers
- Disciplines:Morphological sciences, Oncology
Affiliations
- Pediatric Oncology (Division)
Member
From1 Oct 2016 → Today
Projects
1 - 3 of 3
- Clonal heterogeneity and evolution during chemotherapy in pediatric acute lymphoblastic leukemiaFrom14 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PSEN1-selective gamma-secretase inhibition for the treatment of T-cell acute lymphoblastic leukemia (T-ALL)From25 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Clonal evolution and biology of co-operative oncogenic events in acute lymphoblastic leukemia.From1 Oct 2018 → 30 Sep 2023Funding: Fund Recuperation Fiscal Exemption
Publications
1 - 10 of 37
- Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG)-related retrospective descriptive study(2024)
Authors: Heidi Segers
- Clonal Heterogeneity and Evolution during Treatment in High Hyperdiploid B-Cell Acute Lymphoblastic Leukemia(2023)
Authors: Margo Aertgeerts, Jolien De Bie, Heidi Segers
- The Effect of Immunoglobulin Prophylaxis on Infectious Morbidity in Pediatric Patients with Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial(2023)
Authors: Heidi Segers
- Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity(2023)
Authors: Johanna Jacobs, Robin Duelen, Ward Heggermont, Maurilio Sampaolesi, Heidi Segers, Lucas Van Aelst
- Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)(2023)
Authors: Heidi Segers
Pages: 19480 - 19490 - Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia(2023)
Authors: Charlien Vandersmissen, David Nittner, Johan Maertens, Heidi Segers, Jan Cools
Pages: 2507 - 2512 - Induced Pluripotent Stem Cell-derived Cardiac Myocytes To Assess Anthracycline Cardiotoxicity(2023)
Authors: Johanna Jacobs, Robin Duelen, Ward Heggermont, Heidi Segers
- Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Authors: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pages: 1862 - 1878 - Effect of chemotherapy (with and without radiotherapy) on the intelligence of children and adolescents treated for acute lymphoblastic leukemia; a meta-analysis(2023)
Authors: Jurgen Lemiere, Charlotte Sleurs, Heidi Segers, Marina Danckaerts
Pages: 492 - 505 - Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients(2022)
Authors: Heidi Segers